Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEISB.L Regulatory News (EISB)

  • There is currently no data for EISB

DirectorsTalk Interview

26 Feb 2024 07:00

RNS Number : 3281E
East Imperial PLC
26 February 2024
Β 

RNS Reach

Β 

26 February 2024

East Imperial plc

("East Imperial" or the "Company")

Interview with US Commercial Director, Jaron Berkhemer

East Imperial plc, the global purveyor of super-premium beverages, highlights the recent Director's Talk interview conducted by its US Commercial Director, Jaron Berkhemer, in which he discusses the Company's strategic efforts to enhance its presence in the US market. Jaron shares insights into the significance of quality mixers in elevating the cocktail experience and East Imperial's commitment to authenticity, heritage, and tradition.

Β 

He goes on to highlight recent partnerships, growing consumer trends, and East Imperial's overall vision for leading the premium mixer category in the United States.

Β 

Jaron, who joined East Imperial in August 2023 to spearhead US Operations, has a strong track record in delivering growth in the Beverage and Spirits industries, having previously held senior sales and marketing positions with Bulldog Gin (which quickly became the fourth largest Gin category in the United States, and was bought out by Private Equity), Lucas Bols B.V. and Q Mixers.

Β 

Β 

Link to interview:

https://www.directorstalkinterviews.com/east-imperial-elevating-the-us-mixer-market-video/4121143885#:~:text=He%20discusses%20the%20company's%20approach,through%20innovation%20and%20consumer%20education.

Β 

Β 

Anthony Burt, CEO & Executive Chairman of East Imperial plc, commented:

Β 

"Jaron and his team have had an immediate impact on driving growth for the East Imperial brand in the United States, which I believe the content of this interview demonstrates well. I look forward to the Company being able to announce ongoing wins from the United States territory over the course of 2024 and beyond."

Β 

Β 

For further information, please contact:

East Imperial plc

Anthony Burt

Β 

investors@eastimperial.com

Allenby Capital Limited (Broker)

Guy McDougall / Matt Butlin (Sales and Corporate Broking)

Jeremy Porter / Piers Shimwell (Corporate Finance)

+44 (0)20 3328 5656

Β 

Β 

About East Imperial

Founded in New Zealand and Singapore in 2012, East Imperial produces a range of super-premium mixers that sell throughout APAC, the US and EMEA. Guided by a clear strategy to capitalise on the growing demand for premiumisation across the beverage industry, East Imperial has sold over 33 million bottles in over 20 countries since its founding, with popular products including Old World Tonic Water, Grapefruit Tonic Water, Yuzu Tonic Water and Mombasa Ginger Beer. In 2023, East Imperial won 8 medals at the coveted Tonic & Mixers Masters Competition in London.

Β 

The Company was founded on the philosophy of creating exquisite products defined by heritage, tradition, and authenticity. All products are made from the highest quality, all-natural ingredients, reflecting East Imperial's commitment to providing a sustainable product and minimising environmental impacts at every stage of the manufacturing process. For more information about East Imperial and its ultra-premium mixers.

Β 

Visit https://www.eastimperial.com/

Β 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NRATJMITMTATBLI
Date   Source Headline
24th Nov 20227:00 amRNSAppointment of US Bottling Partner
17th Oct 202210:00 amRNSTR1 notification
14th Sep 202211:06 amRNSSecond Price Monitoring Extn
14th Sep 202211:00 amRNSPrice Monitoring Extension
14th Sep 20227:00 amRNSInterim results
1st Sep 20227:10 amRNSAppointment of WH Ireland as Joint Broker
12th Aug 20229:05 amRNSSecond Price Monitoring Extn
12th Aug 20229:00 amRNSPrice Monitoring Extension
12th Aug 20227:00 amRNSChina Distribution Agreement
21st Jul 20227:00 amRNSPre-Close Trading Statement
1st Jun 20221:44 pmRNSResult of AGM
27th May 20222:00 pmRNSNotice of AGM: Correction
10th May 20227:00 amRNSPosting of Annual Report and Notice of AGM
5th May 20227:00 amRNSFull Year Results
29th Apr 202212:40 pmRNSShort Delay to Publication of Annual Report
8th Apr 20224:41 pmRNSSecond Price Monitoring Extn
8th Apr 20224:35 pmRNSPrice Monitoring Extension
3rd Mar 20222:05 pmRNSSecond Price Monitoring Extn
3rd Mar 20222:00 pmRNSPrice Monitoring Extension
25th Feb 20228:46 amRNSDirectorship Change
18th Feb 20229:47 amRNSDirector/PDMR Shareholding
19th Jan 20227:00 amRNSUS Distribution Agreement
13th Jan 20227:00 amRNSPlacing and year-end update
10th Dec 20215:00 pmRNSDirector/PDMR Shareholding
9th Dec 20219:00 amRNSDirector/PDMR Shareholding
3rd Dec 20212:23 pmRNSDirectorate Changes and Withdrawal of Requisition
17th Nov 20217:00 amRNSRequisition of Extraordinary General Meeting
5th Nov 20217:00 amRNSSingapore Distribution Partner
1st Nov 20217:00 amRNSAppointment of Head of Sales for North America
19th Oct 20217:00 amRNSAppointments to new Strategic Advisory Board
29th Sep 202112:56 pmRNSShareholder Update
13th Sep 20217:00 amRNSTrading Update
13th Sep 20217:00 amRNSBermele Interim Accounts
7th Sep 20214:41 pmRNSSecond Price Monitoring Extn
7th Sep 20214:36 pmRNSPrice Monitoring Extension
7th Sep 20212:05 pmRNSSecond Price Monitoring Extn
7th Sep 20212:00 pmRNSPrice Monitoring Extension
27th Aug 20214:40 pmRNSSecond Price Monitoring Extn
27th Aug 20214:35 pmRNSPrice Monitoring Extension
27th Aug 20219:05 amRNSSecond Price Monitoring Extn
27th Aug 20219:00 amRNSPrice Monitoring Extension
27th Aug 20217:37 amRNSNew Supply Agreements
16th Aug 20212:05 pmRNSSecond Price Monitoring Extn
16th Aug 20212:00 pmRNSPrice Monitoring Extension
6th Aug 20217:00 amRNSSupply Agreement
27th Jul 20214:40 pmRNSSecond Price Monitoring Extn
27th Jul 20214:35 pmRNSPrice Monitoring Extension
27th Jul 20212:06 pmRNSSecond Price Monitoring Extn
27th Jul 20212:00 pmRNSPrice Monitoring Extension
23rd Jul 20217:00 amRNSChange of Name

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.